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Background/aim: Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been
frequently used in the treatment of these infections. This study was designed to investigate the prevalence of primary carbapenem
hydrolyzing oxacillinase (CHO) types in clinical A. bumannii strains.
Materials and methods: Minimum inhibitory concentration (MIC) values of 76 imipenem nonsusceptible A. baumannii strains,
isolated from a tertiary care hospital, were determined by microdilution method. The clonal relationship of the isolates was analyzed
with enterobacterial repetitive intergenic consensus (ERIC)-PCR, and the presence of CHO major groups (OXA-23; OXA-24, OXA-51,
and OXA-58 groups) was investigated with multiplex PCR.
Results: According to the ERIC-PCR patterns, the isolates were distributed in 13 different clones, the largest of which had 40 members.
blaOXA-51-group was detected in representatives of all clones, whereas blaOXA-23-group was detected in representatives of all but two small clones.
Additionally, the presence of blaOXA-58-group was discovered in the members of two small clones, whereas blaOXA-24-group was not encountered
in any of the examined strains.
Conclusion: Molecular fingerprinting revealed that most imipenem-resistant A. baumannii strains were clonally related. blaOXA-23-group
and blaOXA-51-group were mostly responsible for the imipenem resistance of the examined A. baumannii strains.
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1. Introduction
Acinetobacter
baumannii
is
a
gram-negative,
nonfermentative coccobacillus. It is increasingly
recognized as a major pathogen causing nosocomial
infections, including ventilator-associated pneumonia,
bacteremia, meningitis, urinary tract, and wound
infections, particularly in patients admitted to burn
therapy and intensive care units (1). One of the most
alarming characteristics of this bacterium is its ability to
develop resistance to the majority of available antibiotics,
including carbapenems, which are drugs of choice in
severe infections (2). Several mechanisms responsible
for resistance to carbapenems have been described
in A. baumannii isolates: decreased outermembrane
permeability, efflux-pumps, target-site modifications,
and synthesis of carbapenemases (3). Among these,
production of carbapenem-hydrolyzing oxacillinases
(CHOs) or class D carbapenemases stands out as the most

common resistance mechanism (4,5). The Amber class D
carbapenemases of A. baumannii can be divided into six
subgroups: OXA-51-like (intrinsic-chromosomal), OXA23-like, OXA-40/24-like, OXA-58-like, OXA-143-like,
and OXA-235-like (6). Types and frequency of CHOs may
vary among different countries and centers. The aim of this
study was to investigate the prevalence of primary CHO
types in clinical A. baumannii strains isolated from a 2000bed regional university hospital.
2. Materials and methods
2.1. Bacterial strains and determination of imipenem
minimum inhibitory concentration values
Seventy-six carbapenem nonsusceptible clinical A.
baumannii isolates, one per patient, were selected from 122
clinical isolates collected between January and March 2012
by Ege University Hospital, Turkey. Isolates were obtained
from blood (n = 18), tracheal aspirates (n = 28), bronchial
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aspirates (n = 1), bronchoalveolar lavage (n = 7), urine
(n = 9), bile (n = 1), wounds (n = 3), sputum (n = 7), and
wounds (n = 2). A. baumannii isolates were identified
with standard microbiological-biochemical methods and
Vitek-2 (Biomerieux). Identification of the isolates was
additionally confirmed with PCR amplification of the
OXA-51-like gene.
The minimum inhibitory concentrations (MICs)
of imipenem against 76 A. baumannii isolates were
determined with the microdilution method, according
to the Clinical Laboratory Standard Institute (CLSI)
recommendations (7). The final concentrations of
imipenem (Santa Cruz, USA) were adjusted between
0.125 and 128 mg/L. Pseudomonas aeruginosa ATCC
27853 was used for quality control. The lowest antibiotic
concentration that inhibits growth is considered the MIC
value.
2.2. Enterobacterial repetitive intergenic consensus PCR
The genetic relationship of 76 clinical A. baumannii
isolates was determined with enterobacterial repetitive
intergenic consensus-PCR (ERIC-PCR). All primers
used in this study are listed in Table 1. DNA was
extracted by boiling the suspension of a colony for 10
min. The supernatant of this suspension was used as
the PCR template. All reactions were performed in a
25 µL-volume, containing 1.5 U of hot-start Taq DNA
polymerase (Thermo Scientific, USA). Cycling conditions
were 95 °C for 5 min, followed by 35 cycles of 94 °C for
1 min, 40 °C for 1 min, and 72 °C for 1 min, with a final
extension at 72 °C for 10 min. DNA band patterns were
analyzed with an imaging device (Vilber Lourmat fusion
FX-7) following electrophoresis on agarose gels (1.5%
w⁄v). To evaluate similarity between the strains, Jaccard
coefficients [SJ = nAB × 1/(nAB + a + b)] were calculated
according to the banding patterns. When the calculated
SJ was <0.8, two isolates were accepted as ‘clonally
distinct’. Isolates were classified as ‘clonally related’ when

the calculated value was 0.8 ≤ SJ < 1.0; when it was 1.0,
the isolates were considered as ‘identical’. Dendrograms
were formed using Jaccard coefficients and MEGA 4 with
UPGMA method (8). Representatives of each ERIC-PCR
pattern were used for the detection of basic CHO types
with multiplex-PCR.
2.3. Detection of basic carbapenem hydrolyzing
oxacillinase types with multiplex-PCR
CHO group determinants were detected in a total of 22
strains, which were representatives of each clone and
subtype determined by ERIC-PCR. The presence of OXA51-like, OXA-23-like, OXA-40/24-like, and OXA-58-like
genes was investigated with multiplex PCR, as previously
described (4). PCR amplifications were performed in 50μL reaction volumes containing 0.2 mM of primer mix,
0.2 mM dNTP (Thermo Scientific), 5 μL of genomic DNA
extract, 1 U of hot start Taq DNA polymerase (Thermo
Scientific), and 1x of supplied PCR buffer. In addition,
separate PCRs were performed with primers specific
to each CHO group. The 50-μL reaction mixture was
composed of 1.75 mM MgCl2, 0.2 mM dNTPs, 50 pmol of
each primer, and 1.5 U of hot start Taq DNA polymerase.
The amplification conditions were initial denaturation at
95 °C for 5 min, 30 cycles of 94 °C for 1 min, 50 °C for 1
min, 72 °C for 1 min, and a final elongation at 72 °C for 10
min. A. baumannii strains confirmed to be positive for the
CHO group determinants in a previous study were used
as positive controls in this study (9).
All positive results were confirmed by direct
sequencing of the PCR products (Macrogen Inc., Korea).
Sequence analysis results were compared with the
reference sequences at the level of both nucleotide and
amino acid, using European Bioinformatics Institute
(EBI) and National Center for Biotechnology Information
(NCBI) web-based services. Reference sequences used for
blaOXA-23, blaOXA-51, and blaOXA-58 were CP001182, AJ309734,
and AY665723, respectively.

Table 1. Primers used in this study.
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Primer

Sequence (5’ to 3’)

Tm

Amplicon size (bp)

OXA-23-F

5’-GAT CGG ATT GGA GAA CCA GA

58 °C

501

OXA-23-R

5’-ATT TCT GAC CGC ATT TCC AT

54 °C

501

OXA-51-F

5’-TAA TGC TTT GAT CGG CCT TG

56 °C

353

OXA-51-R

5’-TGG ATT GCA CTT CAT CTT GG

56 °C

353

OXA-58-F

5’-AAG TAT TGG GGC TTG TGC TG

58 °C

599

OXA-58-R

5’-CCC CTC TGC GCT CTA CAT AC

63 °C

599

OXA-24-F

5’-GGT TAG TTG GCC CCC TTA AA

58 °C

246

OXA-24-R

5’-AGT TGA GCG AAA AGG GGA TT

56 °C

246

ERIC-2

5’-AAG TAA GTG ACT GGG GTG AGC G

-

-

DAVANDEH et al. / Turk J Med Sci
3. Results
IMP MIC values of the studied 76 clinical isolates of A.
baumannii ranged from 8 to 128 mg/L (Table 2). Seventytwo (94.74%) of the isolates were resistant (MIC ≥ 16 mg/L)
and four (5.26%) isolates were intermediately resistant (8
mg/L) to IMP.
Four to ten bands with sizes ranging from 250 to 1500
bp were formed with ERIC-PCR. According to the ERICPCR band patterns, seven main groups (I–VII) and 13
different clones (A–M) were determined among the studied
A. baumannii strains (Figure 1). The largest clone (clone
A) had three subtypes and 40 members, corresponding to
52.63% of all isolates. Aside from clone A, nine-membered
clone B, 14-membered clone C, and two-membered clones
G, K, and L were identified. In addition, seven clones with
only one member were observed.
Basic CHO groups (blaOXA-51-like, blaOXA-23-like, blaOXA-40/24and blaOXA-58-like) were sought in a total of 22 strains,
like,
which were representatives of each clone and subtype
determined by ERIC-PCR. Chromosomal blaOXA-51-like was
detected in all studied isolates. blaOXA-23-like was determined
in representatives of all clones, except clones K and L.
Instead, blaOXA-58-like was found in members of these clones
(K and L) (Figure 2). blaOXA-40/24-like was not observed in any
of the examined strains. Distribution of CHOs among 22
A. baumannii isolates, which are representatives of each
clone and subtype, and IMP MIC values are shown in
Table 3. To confirm the results obtained by multiplex PCR,
separate PCRs were performed with primers specific to
each CHO group, and PCR products were sequenced for
both directions. Bioinformatic data were consistent with
the multiplex PCR results.
4. Discussion
Carbapenems are among the most effective beta-lactam
antibiotics and are frequently used in the treatment of
infections caused by nosocomial gram-negative pathogens
such as A. baumannii. The positive selective pressure
caused by increased use of carbapenems has resulted
in emergence and expansion of resistance in common
gram-negative pathogens (10). Although metalloenzymes
are particularly common in East Asia, carbapenemases
belonging to molecular class D (CHO) are considered
to be the main mechanism responsible for carbapenem
resistance in A. baumannii isolates (4,5).
IMP MIC values were ≥32 mg/L in 71.05% of the
examined strains in this study, which suggested that IMP
resistance was high and widespread among A. baumannii
isolates in our hospital. The results of ERIC-PCR have
shown that 63 (82.9%) of 76 isolates belonged to one of
three major clones, and the rest (17.1%) were distributed
among 10 other small clones. Many studies carried out in
Turkey have revealed that CHO-detected A. baumannii

Table 2. IMP MIC values of 76 clinical A. baumannii isolates.
MIC (mg/L)

128

64

32

16

8

Number of isolates

4

22

28

18

4

isolates were mostly clonally related in medical centers
(11,12). For example, in a study investigating the prevalence
of OXA-type carbapenemases in carbapenem-resistant A.
baumannii strains isolated from two major medical centers
in Turkey, resistance was reported largely due to the strains
showing clonal relationship in both centers (13). Moreover,
certain clones (international clones-IC I–III) have been
found responsible for spreading imipenem nonsusceptible
A. baumannii isolates throughout the world, and they
often carry CHOs (14). BlaOXA-23-producing A. baumannii
strains that belong to IC-II are also reported to be prevalent
in the Mediterranean region (6). It is necessary to apply
a further molecular typing method, such as multilocus
sequence typing (MLST), for international comparison of
our strains.
As expected, blaOXA-51-group was detected in representatives
of all clones in this study. While blaOXA-23-group was found in
representatives of all but two small clones (two-membered
clones), blaOXA-58-group was identified only in members of
these two clones. In accordance with the results of our
study, blaOXA-23-group dominance is seen in many studies
conducted in Turkey. For example, in a study investigating
CHO prevalence in 834 clinical A. baumannii strains,
isolated from 13 Turkish university and state hospitals
between 2008 and 2011, the rates of blaOXA-23-group and
blaOXA-58-group positive strains were determined to be 74.4%
and 17.3%, respectively (15). Moreover, blaOXA-24-group was
not encountered in any isolate examined in that study.
Although blaOXA-58 has long been the most common type
of CHO in carbapenem-resistant A. baumannii isolates in
Mediterranean countries, it is reported to be substituted
by blaOXA-23 since 2009 (6). BlaOXA-23-group-producing,
carbapenem-resistant A. baumannii isolates are detected
in many countries, suggesting that this gene is common
worldwide (16,17). In another Turkish study, blaOXA-23-group
was detected in 26 (59.1%) of 44 carbapenem-resistant A.
baumannii isolates collected from two hospitals in İstanbul
and Ankara (13). Twenty-five of these blaOXA-23-group-positive
strains were isolated from İstanbul, which reveals that the
prevalence of CHOs may show huge variability between
medical centers.
As in many studies conducted in Turkey, blaOXA-24-group
was not observed in any of the isolates examined in our
study. However, in a study conducted in İzmir, blaOXA-72,
a variant of group OXA-24/40, was identified in an A.
baumannii isolate for the first time in Turkey (18). These
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Figure 1. Dendrogram of A. baumannii isolates (I–VII: main groups, A–M: clones).
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Figure 2. Multiplex PCR products of 22 A. baumannii isolates representing all clones and subtypes (M: 50-bp marker, -:
negative control, OXA-51: 353 bp, OXA-23: 501 bp, OXA-58: 599 bp).
Table 3. Carbapenem-hydrolyzing oxacillinases (CHOs), clones, and imipenem (IMP) MIC values of 22
Acinetobacter baumannii isolates, which are representatives of each clone and subtype.
Strain
No

Clone

IMP MIC
(mg/L)

Detected CHO genes
OXA-51-like

OXA-23-like

OXA-58-like

12
13
17
26
27
33
34
35
40
50
53
55
58
62
68
75
80
81
89
101
108
121

H
A3b
A1
F
B2b
G1
K1
L1
A3a
E
B1
M
C
K2
B2a
D
I
L2
G2
A2a
A2b
J

16
16
16
32
64
16
64
64
16
64
16
64
32
64
32
64
64
64
64
128
32
16

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
–
–
+
+
+
+
+
–
+
+
+
–
+
+
+
+

–
–
–
–
–
–
+
+
–
–
–
–
–
+
–
–
–
+
–
–
–
–

22

18

4

Total 22

OXA-24-like

0
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findings suggest that the blaOXA-24-group is not yet common
in Turkey, although its prevalence should be monitored
carefully.
Our results indicate that most imipenem-resistant A.
baumannii isolates were clonally related in our hospital,
and two CHO groups (blaOXA-51-group and blaOXA-23-group) were
responsible for imipenem resistance. It has been suggested
that infection control measures should be applied strictly,
and appropriate training should be provided to hospital
staff to prevent the spread of carbapenem-resistant

A. baumannii isolates. It is essential to carry out such
molecular epidemiological studies to take the necessary
measures against pathogens such as carbapenem-resistant
A. baumannii strains.
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